Bone Health in Patients with Type 2 Diabetes Treated by Roux-En-Y Gastric Bypass and the Role of Diabetes Remission.
Lene Ring MadsenRasmus EspersenMarie Juul OrnstrupNiklas Rye JørgensenBente Lomholt LangdahlBjørn RichelsenPublished in: Obesity surgery (2020)
Individuals with T2D treated by RYGB, compared to individuals with T2D of similar age and body composition not treated by RYGB, have lower BMD, lower bone strength, and increased levels of several bone turnover markers. Bone health was not associated with current diabetes status in the RYGB group.
Keyphrases
- roux en y gastric bypass
- bone mineral density
- body composition
- weight loss
- postmenopausal women
- gastric bypass
- obese patients
- type diabetes
- healthcare
- public health
- bone loss
- soft tissue
- cardiovascular disease
- bone regeneration
- bariatric surgery
- mental health
- resistance training
- glycemic control
- health information
- newly diagnosed
- adipose tissue
- risk assessment
- systemic lupus erythematosus
- insulin resistance
- human health